Gérald Gavory
Impact in
-
- Ubiquitin and proteasome pathways
- Advanced biosensing and bioanalysis techniques
- Protein Degradation and Inhibitors
- RNA Interference and Gene Delivery
- DNA and Nucleic Acid Chemistry
- Histone Deacetylase Inhibitors Research
-
- Cancer-related Molecular Pathways
Papers in
-
- RNA Interference and Gene Delivery 5
- Advanced biosensing and bioanalysis techniques 4
- Ubiquitin and proteasome pathways 4
- DNA and Nucleic Acid Chemistry 3
- PI3K/AKT/mTOR signaling in cancer 2
- Oncology 7
- Cancer-related Molecular Pathways 4
- Peptidase Inhibition and Analysis 2
- Co-authors
- Shankar Balasubramanian (5 shared papers)C. O'Dowd (7 shared papers)Keeva McClelland (3 shared papers)Matthew Helm (3 shared papers)Jakub Flasz (3 shared papers)Oliver Barker (4 shared papers)Timothy Harrison (4 shared papers)Natalie Page (4 shared papers)
- Journals
- Cancer Research (4 papers)Scientific Reports (2 papers)Biochemistry (2 papers)Chemical Communications (1 paper)ACS Medicinal Chemistry Letters (1 paper)
- Partner nations
- United KingdomSwitzerlandSouth Sudan
In The Last Decade
Gérald Gavory
15 papers receiving 383 citations
Peers
Comparison fields: 5 of 48
- Molecular Biology 357
- Oncology 117
- Physiology 47
- Aging 3
- Epidemiology 51
Countries citing papers authored by Gérald Gavory
This map shows the geographic impact of Gérald Gavory's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Gérald Gavory with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Gérald Gavory more than expected).
Fields of papers citing papers by Gérald Gavory
This network shows the impact of papers produced by Gérald Gavory. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Gérald Gavory. The network helps show where Gérald Gavory may publish in the future.
Co-authors
The 25 scholars most cited alongside Gérald Gavory, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2017 | 165 | |
| 2 | 2018 | 50 | |
| 3 | 2004 | 43 | |
| 4 | 2002 | 30 | |
| 5 | 2002 | 25 | |
| 6 | 2006 | 23 | |
| 7 | 2004 | 21 | |
| 8 | 2024 | 9 | |
| 9 | 2022 | 8 | |
| 10 | 2019 | 5 | |
| 11 | 2015 | 2 | |
| 12 | Mebendazole: A candidate FDA approved drug for repurposing in leukaemia | 2016 | 2 |
| 13 | 2016 | 1 | |
| 14 | 2010 | 1 | |
| 15 | PNA and Oligonucleotide Inhibitors of Human Telomerase | 2013 | 1 |
| 16 | 2024 | 0 |
About Gérald Gavory
Gérald Gavory is a scholar working on Molecular Biology, Oncology, Physiology, Epidemiology and Cell Biology, having authored 16 papers that have together received 386 indexed citations. Recurring topics across this work include RNA Interference and Gene Delivery (5 papers), Advanced biosensing and bioanalysis techniques (4 papers), Telomeres, Telomerase, and Senescence (4 papers), Cancer-related Molecular Pathways (4 papers), Ubiquitin and proteasome pathways (4 papers), DNA and Nucleic Acid Chemistry (3 papers), Peptidase Inhibition and Analysis (2 papers) and PI3K/AKT/mTOR signaling in cancer (2 papers). The work is most often cited by research in Molecular Biology (357 citations), Oncology (117 citations), Physiology (47 citations), Aging (3 citations) and Epidemiology (51 citations). Gérald Gavory has collaborated with scholars based in United Kingdom, Switzerland and South Sudan. Frequent co-authors include Shankar Balasubramanian, C. O'Dowd, Keeva McClelland, Matthew Helm, Jakub Flasz, Oliver Barker, Timothy Harrison, Natalie Page, Hugues Miel and Yen Choo. Their work appears in journals such as Cancer Research, Scientific Reports, Biochemistry, Chemical Communications and ACS Medicinal Chemistry Letters.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.